Delivery Order SPE2DE24D0021-SPE2D626F7638
- Not listed
- Fisher Scientific Company L.L.C. was awarded a delivery order on August 4, 2025, for BinaxNow COVID-19 antigen over-the-counter rapid test kits (12 tests per 2-count case) valued at $1,311.20. This fixed-price delivery order with economic price adjustment was issued by the Medical Supply Chain division within the Department of Defense and is set to be completed by August 11, 2025. The contract represents a child award under a larger vehicle and specifies performance in Pittsburgh,...
- Fisher Scientific Company L.L.C. was awarded a delivery order valued at $1,176.00 on September 16, 2025, for the supply of BinaxNOW COVID-19 antigen testing kits to support the Medical Supply Chain program within the Department of Defense. The contract utilizes a fixed-price structure with economic price adjustment provisions and is scheduled for completion by September 23, 2025. As a child contract under a larger vehicle, this delivery order represents Fisher Scientific's role as a critical...
- Fisher Scientific Company L.L.C. has been awarded a delivery order valued at $2,205.00 for BinaxNow COVID-19 antigen OTC test kits (12 tests per 2-test case) by the Defense Medical Supply Chain federal agency. The contract, awarded on September 9, 2025, with an ultimate completion date of September 16, 2025, utilizes a fixed price with economic price adjustment pricing structure. The place of performance is Pittsburgh, Pennsylvania. This delivery order represents a child contract, indicating...
- Fisher Scientific Company L.L.C. was awarded a delivery order contract for BinaxNow COVID-19 antigen testing kits on September 16, 2025, with a ceiling value of $1,960. The contract, issued by the Defense Medical Supply Chain, is structured as a fixed-price delivery order with economic price adjustment provisions and carries no set-aside designation, reflecting open competition in the award process. Performance will be executed in Pittsburgh, Pennsylvania, with an ultimate completion date of...
- Fisher Scientific Company L.L.C. was awarded a delivery order valued at $1,076.64 on August 21, 2025, for the procurement of BinaxNow COVID-19 antigen testing kits. The contract is structured as a fixed-price delivery order with economic price adjustment provisions and is funded by the Defense Department's Medical Supply Chain division. Performance will be completed in Pittsburgh, Pennsylvania, with an ultimate completion date of August 28, 2025. This award represents a child contract with no...
- Fisher Scientific Company L.L.C. was awarded a delivery order valued at $2,322.00 for BinaxNOW COVID-19 antigen testing kits on April 30, 2025, with an ultimate completion date of May 7, 2025. This fixed-price contract with economic price adjustment was issued by the Medical Supply Chain, a defense-oriented federal agency, and will be performed in Pittsburgh, Pennsylvania. As a child contract, this delivery order is part of a larger contracting vehicle, leveraging Fisher Scientific's established...
- Fisher Scientific Company L.L.C. received a fixed-price delivery order contract from the Medical Supply Chain, a defense-focused federal agency, for the procurement of BinaxNOW COVID-19 antigen testing kits. The contract, valued at $2,156.00, was awarded on September 10, 2025, with an ultimate completion date of September 17, 2025. Performance will take place in Pittsburgh, Pennsylvania. This delivery order represents a child contract with no set-aside designation, awarded through open...
- Fisher Scientific Company L.L.C. received a delivery order award valued at $3,920 for BinaxNow COVID-19 test kits under a fixed-price contract with economic price adjustment. The order, issued on September 16, 2025, with an ultimate completion date of September 23, 2025, will be performed in Pittsburgh, Pennsylvania. This is a child contract with no set-aside designation, awarded through open competition to support the Medical Supply Chain, a defense-focused federal agency function. Fisher...
- Fisher Scientific Company L.L.C. was awarded a fixed-price delivery order against an unidentified contract vehicle by the Defense Logistics Agency Troop Support Medical for $1,147.32. Under this delivery order, Fisher Scientific will provide BINAXNOW COVID-19 antigen testing kits to support the agency's medical response efforts. Headquartered in Pittsburgh, Pennsylvania, Fisher Scientific is a for-profit limited liability company and distributor of laboratory supplies that has received...
- Fisher Scientific Company L.L.C. was awarded a delivery order valued at $1,470.00 by the Defense Medical Supply Chain on August 19, 2025, for the supply of BinaxNOW COVID-19 antigen over-the-counter test kits (12 tests per box, 2 boxes per case). This fixed-price contract with economic price adjustment provisions represents a child contract under a larger vehicle and carries no set-aside designation. The order is scheduled for completion by August 26, 2025, with performance directed to...
- SPE2DE24D0021Indefinite Delivery Contract
- SPE2DE24D0021-SPE2D626F7638Delivery Order
Fisher Scientific Company L.L.C. was awarded a delivery order valued at $1,176.00 by the Department of Defense's Medical Supply Chain for the provision of BinaxNOW COVID-19 antigen testing kits. The contract was awarded on October 30, 2025, with an ultimate completion date of November 6, 2025, and will be performed in Pittsburgh, Pennsylvania. This delivery order represents a fixed-price contract with economic price adjustment provisions and was issued without set-aside designations, indicating open competition. As a child contract, this award likely derives from a larger indefinite delivery vehicle or General Services Administration Multiple Award Schedule contract through which the Department of Defense procures laboratory and medical supplies. Fisher Scientific has established itself as a critical federal supplier of scientific products and laboratory equipment across multiple government agencies. The company's extensive contract portfolio with the Department of Veterans Affairs, Department of Defense, and civilian health agencies demonstrates its capability to reliably deliver specialized diagnostic equipment and medical consumables supporting federal healthcare and research operations. Fisher Scientific's SAM.gov registration since July 2001 and its primary place of business in Pittsburgh, Pennsylvania, reflect its longstanding role as a preferred vendor for federal laboratory and diagnostic procurement requirements.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.2k | 10/30/25 |